Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs KERNX Health
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict56/ 100
Grade C · #370KERNX Health
Washington DC telehealth platform with month-to-month compounded GLP-1 plans, undermined by a pricing page that contradicts itself on whether consultations cost extra.
Visit KERNX HealthThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 56/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. KERNX Health still earns its place — buyers who want month-to-month billing with no prepayment and will budget for the separate per-visit fee.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results60
92
Real-world results60
97Price honesty40
97
Price honesty40
96Prescriber access70
96
Prescriber access70
88Formulary choice40
88
Formulary choice40
95Cancellation fairness80
95
Cancellation fairness80
93Member support50
93
Member support50
Price, coverage & features
| Metric | CoreAge Rx | KERNX Health |
|---|---|---|
| Verdict Score | 94/100 | 56/100 |
| Grade | A | C |
| Semaglutide | $149/mo | $249/mo standard |
| Tirzepatide | $349/mo | $299/mo standard |
| Coverage | All 50 states | Multi-state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
KERNX Health
What we like
- Plan pricing is published openly before any intake or account creation
- Month-to-month billing with no long-term contract and no multi-month prepayment
- Billing begins only after a licensed provider approves treatment
- LegitScript certification checks out against issued seal ID 50286246, not merely a badge image
- Cancel before the next renewal date from the account or by email, which stops all future charges
The caveats
- Compounded semaglutide and tirzepatide are not FDA-approved finished products and have not been reviewed for safety, effectiveness or quality
- The pricing page contradicts itself: one section says there are no separate consultation charges, another says $25-$60 applies per visit
- That consultation fee is charged whether or not a prescription is issued
- The $129 and $199 rates are time-limited founding rates; standard rates are $249 and $299, roughly double
- No compounding pharmacy is named, only described as an FDA-registered 503B facility
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Buyers who want month-to-month billing with no prepayment and will budget for the separate per-visit fee.
Visit KERNX Health Read the full KERNX Health review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programmes closest to it, and the same shortlist for KERNX Health does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.